FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912331837> ?p ?o ?g. }

• W2912331837 endingPage "10" @default.
• W2912331837 startingPage "1" @default.
• W2912331837 abstract "Increased evidence reveals that uric acid (UA) may have an important neuroprotective effect through its antioxidant properties. The aim of the present study was to investigate the relationship between pretreatment serum UA levels and the progression of newly diagnosed primary angle-closure glaucoma (PACG).This prospective observational cohort study included 64 patients with newly diagnosed PACG who were followed up for a mean period of 12.77 months (range: 3-28 months). All subjects underwent a complete ophthalmological examination during the baseline and final follow-up visits, together with the acquisition of blood samples for UA measurements. During the follow-up period, the progression of PACG was defined as a clinical diagnosis of medically uncontrolled intraocular pressure and a loss of visual field with a mean deviation of >1 dB/year. Univariable and multivariable Cox regression models were used to investigate the association between baseline serum UA levels and the progression of PACG. The cumulative probability of progression of glaucoma was analyzed using the Kaplan-Meier method.During follow-up, 32 subjects were defined as progressive PACG, among whom baseline UA values were significantly higher in nonprogressing subjects than in progressing subjects (0.314 ± 0.069 mmol/l versus [vs.] 0.258 ± 0.069 mmol/l, respectively; P = 0.002). Similar results were also observed in male and female subgroups (P < 0.05). In a multivariable model, a decreased baseline serum UA level was associated with an increased risk for progressing PACG: both in male (hazard ratio [HR] 6.088 [95% confidence interval (CI) 1.163-31.8638]; P = 0.032) and female subjects (HR 3.565 [95% CI 1.131-11.236]; P = 0.030). Subjects with high UA levels demonstrated higher cumulative probabilities of nonprogressing PACG than those with low UA levels (male [16.67% vs. 80.00%; P = 0.0084] and female [29.41% vs. 68.00%; P = 0.0182]).An association between high baseline serum UA levels and a decreased risk for progressing PACG was found. This primary finding suggests that high serum UA levels may have a protective role against PACG and could slow disease progression." @default.
• W2912331837 created "2019-02-21" @default.
• W2912331837 creator A5040625222 @default.
• W2912331837 creator A5057558848 @default.
• W2912331837 creator A5068760209 @default.
• W2912331837 creator A5091349849 @default.
• W2912331837 date "2019-02-07" @default.
• W2912331837 modified "2023-10-16" @default.
• W2912331837 title "Association between Pretreatment Serum Uric Acid Levels and Progression of Newly Diagnosed Primary Angle-Closure Glaucoma: A Prospective Cohort Study" @default.
• W2912331837 cites W1585342167 @default.
• W2912331837 cites W1836296394 @default.
• W2912331837 cites W1968367657 @default.
• W2912331837 cites W1992081851 @default.
• W2912331837 cites W2000411175 @default.
• W2912331837 cites W2012019710 @default.
• W2912331837 cites W2012391007 @default.
• W2912331837 cites W2024088660 @default.
• W2912331837 cites W2025372788 @default.
• W2912331837 cites W2038297420 @default.
• W2912331837 cites W2054361161 @default.
• W2912331837 cites W2054796275 @default.
• W2912331837 cites W2060208018 @default.
• W2912331837 cites W2076670237 @default.
• W2912331837 cites W2078904393 @default.
• W2912331837 cites W2103913904 @default.
• W2912331837 cites W2107419879 @default.
• W2912331837 cites W2114651971 @default.
• W2912331837 cites W2117104323 @default.
• W2912331837 cites W2119021947 @default.
• W2912331837 cites W2124639061 @default.
• W2912331837 cites W2131101289 @default.
• W2912331837 cites W2138064547 @default.
• W2912331837 cites W2140370824 @default.
• W2912331837 cites W2152446214 @default.
• W2912331837 cites W2154672809 @default.
• W2912331837 cites W2156639894 @default.
• W2912331837 cites W2160507302 @default.
• W2912331837 cites W2160605010 @default.
• W2912331837 cites W2161080101 @default.
• W2912331837 cites W2262374723 @default.
• W2912331837 cites W2362698467 @default.
• W2912331837 cites W2416473080 @default.
• W2912331837 cites W2483549613 @default.
• W2912331837 cites W2525221984 @default.
• W2912331837 cites W2529559314 @default.
• W2912331837 cites W2557667480 @default.
• W2912331837 cites W2559743009 @default.
• W2912331837 cites W2580873907 @default.
• W2912331837 cites W2605337383 @default.
• W2912331837 cites W2741537813 @default.
• W2912331837 cites W2754037448 @default.
• W2912331837 cites W2761899299 @default.
• W2912331837 cites W2773723025 @default.
• W2912331837 cites W2801567826 @default.
• W2912331837 cites W2811153268 @default.
• W2912331837 cites W2887574449 @default.
• W2912331837 cites W4206485229 @default.
• W2912331837 cites W99216986 @default.
• W2912331837 doi "https://doi.org/10.1155/2019/7919836" @default.
• W2912331837 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6383391" @default.
• W2912331837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30881597" @default.
• W2912331837 hasPublicationYear "2019" @default.
• W2912331837 type Work @default.
• W2912331837 sameAs 2912331837 @default.
• W2912331837 citedByCount "5" @default.
• W2912331837 countsByYear W29123318372020 @default.
• W2912331837 countsByYear W29123318372021 @default.
• W2912331837 countsByYear W29123318372023 @default.
• W2912331837 crossrefType "journal-article" @default.
• W2912331837 hasAuthorship W2912331837A5040625222 @default.
• W2912331837 hasAuthorship W2912331837A5057558848 @default.
• W2912331837 hasAuthorship W2912331837A5068760209 @default.
• W2912331837 hasAuthorship W2912331837A5091349849 @default.
• W2912331837 hasBestOaLocation W29123318371 @default.
• W2912331837 hasConcept C118487528 @default.
• W2912331837 hasConcept C126322002 @default.
• W2912331837 hasConcept C141071460 @default.
• W2912331837 hasConcept C188816634 @default.
• W2912331837 hasConcept C201903717 @default.
• W2912331837 hasConcept C207103383 @default.
• W2912331837 hasConcept C2778527774 @default.
• W2912331837 hasConcept C2779881121 @default.
• W2912331837 hasConcept C44249647 @default.
• W2912331837 hasConcept C50382708 @default.
• W2912331837 hasConcept C71924100 @default.
• W2912331837 hasConcept C72563966 @default.
• W2912331837 hasConcept C90924648 @default.
• W2912331837 hasConceptScore W2912331837C118487528 @default.
• W2912331837 hasConceptScore W2912331837C126322002 @default.
• W2912331837 hasConceptScore W2912331837C141071460 @default.
• W2912331837 hasConceptScore W2912331837C188816634 @default.
• W2912331837 hasConceptScore W2912331837C201903717 @default.
• W2912331837 hasConceptScore W2912331837C207103383 @default.
• W2912331837 hasConceptScore W2912331837C2778527774 @default.
• W2912331837 hasConceptScore W2912331837C2779881121 @default.
• W2912331837 hasConceptScore W2912331837C44249647 @default.
• W2912331837 hasConceptScore W2912331837C50382708 @default.
• W2912331837 hasConceptScore W2912331837C71924100 @default.

• next